XRAY

$10.95-0.31 (-2.75%)

Market ClosedAs of Mar 20, 8:00 PM UTC

DENTSPLY SIRONA Inc.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$10.95
Potential Upside
5%
Whystock Fair Value$11.50
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Instruments & Supplies

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Tech...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.19B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.93
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-70.87%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.03

Recent News

Motley Fool
Mar 20, 2026

What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year

This medical technology firm delivers integrated blood management solutions to healthcare providers and plasma centers worldwide.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 18, 2026

How Investors Are Reacting To DENTSPLY SIRONA (XRAY) Launching a First-of-Its-Kind Dental MRI Platform

Dentsply Sirona and Siemens Healthineers recently received FDA clearance in the US for the MAGNETOM Free.Max Dental Edition, the first dental‑dedicated MRI system validated in a clinical trial for multiple dental specialties including endodontics, periodontics, TMJ, extractions, and orthodontics. This radiation‑free imaging technology, featuring a dental‑specific field of view and workflow times under 20 minutes, could reshape complex dental diagnostics for hospitals, large clinics, and...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Motley Fool
Mar 13, 2026

Is Dentsply Sirona Stock a Buy After a Company Director Purchased 15,000 Shares?

This global dental technology firm, with strong recurring revenues, reported a notable insider buy following a year of share price declines.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 12, 2026

3 Cash-Producing Stocks Walking a Fine Line

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 9, 2026

3 Stocks Under $50 Walking a Fine Line

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.